Steve Seedhouse
Stock Analyst at Cantor Fitzgerald
(2.75)
# 2,023
Out of 4,984 analysts
4
Total ratings
100%
Success rate
16.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Overweight | $39 → $40 | $23.82 | +67.93% | 1 | Aug 1, 2025 | |
| INVA Innoviva | Initiates: Overweight | $26 | $19.34 | +34.44% | 1 | Jul 11, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $52 | $34.02 | +52.85% | 1 | Jul 11, 2025 | |
| HROW Harrow | Initiates: Overweight | $76 | $42.89 | +77.22% | 1 | Jul 11, 2025 |
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Overweight
Price Target: $39 → $40
Current: $23.82
Upside: +67.93%
Innoviva
Jul 11, 2025
Initiates: Overweight
Price Target: $26
Current: $19.34
Upside: +34.44%
Tvardi Therapeutics
Jul 11, 2025
Initiates: Overweight
Price Target: $52
Current: $34.02
Upside: +52.85%
Harrow
Jul 11, 2025
Initiates: Overweight
Price Target: $76
Current: $42.89
Upside: +77.22%